Skip to Content
Thoracic Surgery Hennon MW, Kumar A, Devisetty H, et al. Minimally Invasive Approaches Do Not Compromise Outcomes for Pneumonectomy: A Comparison Using the National Cancer Database . J Thorac Oncol. 2019;14(1):107-114. doi:10.1016/j.jtho.2018.09.024 Hennon M, Yendamuri S. Lymph node sampling at the time of sublobar resection - we must learn to walk before we can run [published online ahead of print, 2019 Jan 7] . J Thorac Cardiovasc Surg. 2019;S0022-5223(18)33214-8. doi:10.1016/j.jtcvs.2018.11.085 Yang CJ, Yendamuri S, Mayne NR, et al. The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study [published correction appears in J Thorac Cardiovasc Surg . 2019 Dec 4;:]. J Thorac Cardiovasc Surg. 2019;158(1):252-264.e2. doi:10.1016/j.jtcvs.2018.12.001 Maddi A, Sabharwal A, Violante T, et al. The microbiome and lung cancer . J Thorac Dis. 2019;11(1):280-291. doi:10.21037/jtd.2018.12.88 Fountzilas C, Hochwald SN. Immune checkpoint inhibitors in esophagogastric cancer: still a long way to go . J Thorac Dis. 2019;11(2):351-353. doi:10.21037/jtd.2018.11.111 Hennon M, Yendamuri S. Video assisted thoracoscopic surgery vs . thoracotomy for lobectomy: why are we still talking about this?. J Thorac Dis. 2019;11(Suppl 9):S1284-S1285. doi:10.21037/jtd.2019.04.106 Peng JS, Hochwald SN. Minimally invasive esophagectomy-standard of care . J Thorac Dis. 2019;11(Suppl 9):S1387-S1388. doi:10.21037/jtd.2019.03.43 Chapman BC, Weyant M, Hilton S, et al. Analysis of the National Cancer Database Esophageal Squamous Cell Carcinoma in the United States . Ann Thorac Surg. 2019;108(5):1535-1542. doi:10.1016/j.athoracsur.2019.05.053 Yendamuri S, Barbi J, Pabla S, et al. Body Mass Index Influences the Salutary Effects of Metformin on Survival After Lobectomy for Stage I NSCLC . J Thorac Oncol. 2019;14(12):2181-2187. doi:10.1016/j.jtho.2019.07.020 Linden PA, Perry Y, Worrell S, et al. Postoperative day 1 discharge after anatomic lung resection: A Society of Thoracic Surgeons database analysis [published online ahead of print, 2019 Sep 13] . J Thorac Cardiovasc Surg. 2019;S0022-5223(19)31773-8. doi:10.1016/j.jtcvs.2019.08.038 Demmy TL. Commentary: Leveraging operative exposure-Future "targeted" opportunity or disappointment? [published online ahead of print, 2019 Sep 24] . J Thorac Cardiovasc Surg. 2019;S0022-5223(19)32046-X. doi:10.1016/j.jtcvs.2019.09.051 Demmy TL. Commentary: Expanding the legacy of unusual malignancy research [published online ahead of print, 2019 Oct 1] . J Thorac Cardiovasc Surg. 2019;S0022-5223(19)32123-3. doi:10.1016/j.jtcvs.2019.09.108 Demmy TL, Yendamuri S. Oncologic validity of minimally invasive lobectomy for early stage lung cancer . J Thorac Dis. 2019;11(10):E163-E167. doi:10.21037/jtd.2019.09.45 Hennon MW, DeGraaff LH, Groman A, Demmy TL, Yendamuri S. The association of nodal upstaging with surgical approach and its impact on long-term survival after resection of non-small-cell lung cancer . Eur J Cardiothorac Surg. 2020;57(5):888-895. doi:10.1093/ejcts/ezz320 Demmy TL. Commentary: Positive pressure toward a negative trial? [published online ahead of print, 2019 Nov 13] . J Thorac Cardiovasc Surg. 2019;S0022-5223(19)32754-0. doi:10.1016/j.jtcvs.2019.10.141 Pu CY, Yendamuri S. Neoadjuvant versus adjuvant chemotherapy for resectable non-small cell lung cancer debate revisited . J Thorac Dis. 2019;11(12):5646-5648. doi:10.21037/jtd.2019.11.23 Hennon M, Yendamuri S. For radiation therapy before surgery in esophageal cancer, dose matters, and with each answer comes more questions . J Thorac Dis. 2019;11(12):5662-5663. doi:10.21037/jtd.2019.12.62 Yendamuri S. Commentary: A picture really is worth a thousand words [published online ahead of print, 2020 Feb 8] . J Thorac Cardiovasc Surg. 2020;S0022-5223(20)30309-3. doi:10.1016/j.jtcvs.2020.02.003 Hennon MW, DeGraaff LH, Demmy TL, Yendamuri S. Reply to Maier et al . Eur J Cardiothorac Surg. 2020;58(2):403-404. doi:10.1093/ejcts/ezaa045 Patnaik SK, Cortes EG, Kannisto ED, et al. Lower airway bacterial microbiome may influence recurrence after resection of early-stage non-small cell lung cancer [published online ahead of print, 2020 Mar 23] . J Thorac Cardiovasc Surg. 2020;S0022-5223(20)30631-0. doi:10.1016/j.jtcvs.2020.01.104 Towe CW, Worrell SG, Bachman K, Sarode AL, Perry Y, Linden PA. Neoadjuvant treatment is associated with superior outcomes in T4 lung cancers with local extension [published online ahead of print, 2020 Jul 11] . Ann Thorac Surg. 2020;S0003-4975(20)31118-8. doi:10.1016/j.athoracsur.2020.05.084 Demmy TL. Commentary: Dissecting surgical systems [published online ahead of print, 2020 Jun 27] . J Thorac Cardiovasc Surg. 2020;S0022-5223(20)31783-9. doi:10.1016/j.jtcvs.2020.06.053 Towe CW, Srinivasan S, Ho VP, et al. Antibiotic resistance is associated with morbidity and mortality after decortication for empyema [published online ahead of print, 2020 Aug 25] . Ann Thorac Surg. 2020;S0003-4975(20)31351-5. doi:10.1016/j.athoracsur.2020.06.056
Research Funding APOL1 Long-term Kidney Transplantation Outcomes Research Network (APOLLO). We are an APOLLO Network Clinical Centers (CCs) within this multi-center, multi-disciplinary study group following a prospective longitudinal cohort to determine the impact of APOL1 genetic variants as susceptibility factors in US kidney transplant recipients who received kidneys from African American donors. Liise Kayler (Co-Investigator). National Institutes of Diabetes and Digestive and Kidney Disease (NIDDK) of the National Institutes of Health. $229,964. 9/1/2017-9/1/2026. Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication. Liise Kayler (Co-Principal Investigator). NIH. $3,543,724. 8/1/2021-7/1/2025. Impact of the Increase in Availability of Ambulatory Surgery on Treatment Decision Making: A Mixed Methods Study. Jessica Martinolich (Principal Investigator). CTSI. 1/1/2024-12/1/2024.
See all recent funding>